Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1988 Nov-Dec;61(6):493–500.

A possible association between survival time and transfusion in cervical cancer.

N Blumberg 1, M M Agarwal 1, C Chuang 1
PMCID: PMC2590486  PMID: 3242314

Abstract

Some studies suggest that transfusion may be associated with an increased risk of recurrence of and death due to malignant human neoplasms. We examined retrospective data from patients with cervical cancer to see if any association between transfusion of blood at the time of initial treatment and the time interval to recurrence and death could be detected in this cancer. In 130 patients with cervical cancer, seen over a ten-year period at our institution, there was a trend toward earlier recurrence in transfused patients, but this trend did not achieve statistical significance. Death due to cervical cancer recurrence occurred after a median of Death due to cervical cancer recurrence occurred after a median of 12 months in the transfused patients and a median of 68 months in the non-transfused individuals, which was statistically significant. Transfused patients had, on average, more favorable prognostic factors than those not transfused, such as less advanced clinical stage of disease. Analysis using a proportional hazards risk model failed to demonstrate a significant association between transfusion and time to recurrence when other prognostic factors were considered, but a significant association between transfusion and time to cancer-related death (p less than 0.05) was found. While these results cannot be viewed as conclusive due to the small number and heterogeneity of the patients analyzed, our data support the possibility of an association between transfusion and cervical cancer survival. Further studies are warranted to confirm or refute this relationship.

Full text

PDF
493

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blair R., Newsome F. Involvement of water-soluble vitamins in diseases of swine. J Anim Sci. 1985 Jun;60(6):1508–1517. doi: 10.2527/jas1985.6061508x. [DOI] [PubMed] [Google Scholar]
  2. Blumberg N., Agarwal M. M., Chuang C. Relation between recurrence of cancer of the colon and blood transfusion. Br Med J (Clin Res Ed) 1985 Apr 6;290(6474):1037–1039. doi: 10.1136/bmj.290.6474.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blumberg N., Heal J. M., Murphy P., Agarwal M. M., Chuang C. Association between transfusion of whole blood and recurrence of cancer. Br Med J (Clin Res Ed) 1986 Aug 30;293(6546):530–533. doi: 10.1136/bmj.293.6546.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blumberg N., Heal J. M. Perioperative blood transfusion and solid tumour recurrence. Blood Rev. 1987 Dec;1(4):219–229. doi: 10.1016/0268-960x(87)90023-3. [DOI] [PubMed] [Google Scholar]
  5. Blumberg N., Heal J., Chuang C., Murphy P., Agarwal M. Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg. 1988 Apr;207(4):410–415. doi: 10.1097/00000658-198804000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burrows L., Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate. Lancet. 1982 Sep 18;2(8299):662–662. doi: 10.1016/s0140-6736(82)92764-7. [DOI] [PubMed] [Google Scholar]
  7. Foster R. S., Jr, Costanza M. C., Foster J. C., Wanner M. C., Foster C. B. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer. 1985 Mar 15;55(6):1195–1201. doi: 10.1002/1097-0142(19850315)55:6<1195::aid-cncr2820550610>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  8. Foster R. S., Jr, Foster J. C., Costanza M. C. Blood transfusions and survival after surgery for breast cancer. Arch Surg. 1984 Oct;119(10):1138–1140. doi: 10.1001/archsurg.1984.01390220024005. [DOI] [PubMed] [Google Scholar]
  9. Francis D. M., Judson R. T. Blood transfusion and recurrence of cancer of the colon and rectum. Br J Surg. 1987 Jan;74(1):26–30. doi: 10.1002/bjs.1800740110. [DOI] [PubMed] [Google Scholar]
  10. Frankish P. D., McNee R. K., Alley P. G., Woodfield D. G. Relation between cancer of the colon and blood transfusion. Br Med J (Clin Res Ed) 1985 Jun 15;290(6484):1827–1827. doi: 10.1136/bmj.290.6484.1827-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Horimi T., Kagawa S., Ninomiya M., Yoshida E., Hiramatsu S., Orita K. Possible induction by blood transfusion of immunological tolerance against growth of transplanted tumors in mice. Acta Med Okayama. 1983 Jun;37(3):259–263. doi: 10.18926/AMO/32434. [DOI] [PubMed] [Google Scholar]
  12. Hyman N. H., Foster R. S., Jr, DeMeules J. E., Costanza M. C. Blood transfusions and survival after lung cancer resection. Am J Surg. 1985 Apr;149(4):502–507. doi: 10.1016/s0002-9610(85)80047-7. [DOI] [PubMed] [Google Scholar]
  13. Moffat L. E., Sunderland G. T. Relation between recurrence of cancer and blood transfusion. Br Med J (Clin Res Ed) 1985 Oct 5;291(6500):971–971. doi: 10.1136/bmj.291.6500.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nathanson S. D., Tilley B. C., Schultz L., Smith R. F. Perioperative allogeneic blood transfusions. Survival in patients with resected carcinomas of the colon and rectum. Arch Surg. 1985 Jun;120(6):734–738. doi: 10.1001/archsurg.1985.01390300076013. [DOI] [PubMed] [Google Scholar]
  15. Opelz G., Terasaki P. I. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med. 1978 Oct 12;299(15):799–803. doi: 10.1056/NEJM197810122991503. [DOI] [PubMed] [Google Scholar]
  16. Ota D., Alvarez L., Lichtiger B., Giacco G., Guinee V. Perioperative blood transfusion in patients with colon carcinoma. Transfusion. 1985 Jul-Aug;25(4):392–394. doi: 10.1046/j.1537-2995.1985.25485273825.x. [DOI] [PubMed] [Google Scholar]
  17. Rosenberg S. A., Seipp C. A., White D. E., Wesley R. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol. 1985 May;3(5):698–709. doi: 10.1200/JCO.1985.3.5.698. [DOI] [PubMed] [Google Scholar]
  18. Tartter P. I., Burrows L., Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg. 1984 Nov;88(5 Pt 1):659–662. [PubMed] [Google Scholar]
  19. Tartter P. I., Burrows L., Papatestas A. E., Lesnick G., Aufses A. H., Jr Perioperative blood transfusion has prognostic significance for breast cancer. Surgery. 1985 Feb;97(2):225–230. [PubMed] [Google Scholar]
  20. Voogt P. J., van de Velde C. J., Brand A., Hermans J., Stijnen T., Bloem R., Leer J. W., Zwaveling A., van Rood J. J. Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer. 1987 Feb 15;59(4):836–843. doi: 10.1002/1097-0142(19870215)59:4<836::aid-cncr2820590430>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  21. Weiden P. L., Bean M. A., Schultz P. Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Cancer. 1987 Aug 15;60(4):870–874. doi: 10.1002/1097-0142(19870815)60:4<870::aid-cncr2820600425>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  22. Woodruff M. F., van Rood J. J. Possible implications of the effect of blood transfusion on allograft survival. Lancet. 1983 May 28;1(8335):1201–1203. doi: 10.1016/s0140-6736(83)92476-5. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES